Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions

Similar documents
How To Compare Sweden To Danesland

Förhandskopia

Globala trender med lokala effekter

Karriärdagar Uppsala - Vad händer inom bioteknikbranschen?

Life science companies in Sweden Including a comparison with Denmark

The Swedish Drug Development Pipeline. Dec Sara Gunnerås, Senior Manager Science & IP, SwedenBIO SwedenBIO CEO Summit 2013, AstraZenaca Mölndal

The Swedish Drug Development Pipeline 2014

The Swedish Drug Development Pipeline. December & overview of Swedish companies with R&D activities in Sweden

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

For More Information

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

How world-class diabetes research will contribute to Swedish growth

Kurt Strömgren. Business coach - Uminova Innovation Manager Biotech Umeå. Ideas become business.

New York City Economic Development Corporation Lenzie Harcum, Bioscience Desk November, 2009

Tech transfer The Swedish Context. Academia-industry collaboration. .. Created the largest selling drug, LOSEC, followed by Nexium

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore

A BENCHMARKING STUDY OF THE SWEDISH AND BRITISH LIFE SCIENCE INNOVATION SYSTEMS

Cluster Formation Across Borders

E- MARKETPLACES IN THE BIOTECH INDUSTRY

The medical research situation in Sweden Preface

Infrastructure and users Public and private providers/users Issues and approaches Discussion

Performance indicators, quality benchmarking and cost/ efficiency of emergency services. Gunnar Bergström SOS Alarm, Sweden

SYSTEM-OF-SYSTEMS (SOS) WORKSHOP 1 SICS & INCOSE

Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness

Creative Force Eastern Europe and Western Balkans

Fit for Health International Strategy Development Training Innovative Business Solutions and Smart Financing

JOHN REID PhD, MBA. (302)

Event Sponsorship Opportunities

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

Business Incubation for Growth, BIG: A new national incubator program

PDP Funders Group Briefing Paper Background. 2. Methods

Presented at: Jefferies 2015 Global Healthcare Conference

Can public policy regenerate a traditional industry through collaborative research? The case of the Swedish food industry

THE BIOTECH & PHARMACEUTICAL INDUSTRY

The Swedish Drug Development Pipeline June A survey conducted by:

Corporate Governance Report for Orexo AB (publ)

GREEN AND SAFE ROAD VEHICLE TECHNOLOGY CLUSTERS IN WEST SWEDEN SAGE DELIVERABLE 2.2

National Doctoral Programme in Infections and Antibiotics

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

CURRICULUM VITAE (short version)

Automating Cell Biology Annual general meeting, September 7, Phase Holographic Imaging

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE

VTT Technical Research Centre of Finland 2010

Industrial Services Barbro Lagerholm IVF Industrial Research and Development Corporation Bild

HCL Healthcare: Meeting Reform Challenges

ACC San Diego Chapter

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW

Biotech Opportunities for Start-Up Firms in Japan and Asia

Blekinge Institute of Technology. Master Thesis

The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset

Nordic Venture Capital:

Analysis of Chain-linked

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

Denmark. Aarhus University. Aalborg University. University of Copenhagen. IT University of Copenhagen. Nordic Techology Transfer Network

Life Sciences Outlook. New Jersey 2015


A survey conducted by: The Swedish Drug Development Pipeline May 2011

PRT Plans in Swedish Cities by by Göran Tegnér; M.Sc.Econ, Senior Advisor, WSP Sweden

Lund LSI. Lund Life Science Incubator Catalyst for growth. Dan J. Mogren Director Business Development

The Novo Nordisk Foundation Center for Biosustanability, DTU. Presentation of the center at Plastdagen 5 May 2011 by Bo Skjold Larsen, COO.

In the largest and perhaps the most ambitious collaborative

Do Swedish property management companies have necessary conditions for environmental management?

St. George s University

International Council on Systems Engineering. ISO/IEC/IEEE SEminar Linköping 16 november 2015

Photocure ASA. The world leader in photodynamic technology. Sept Ketil F. Widerberg, Director Business Development

TOPRA 2014 TOPRA IN SWEDEN. Margareth Jorvid TOPRA In Sweden Working Party

Economic and Social Council

Knowledge Transfer in Mexico Dr Mireya McKee, Senior Consultant Isis Enterprise June 16 th, Copyright 2016 Isis Innovation Ltd.

2015 / 2016 Awards Criteria and Submission Information

APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015

State of the Life Sciences Mergers and Acquisitions Market

Six Sigma Workshop Fallstudie och praktisk övning

SWEDEN SWEDEN PHYSICAL ACTIVITY FACTSHEET PREVALENCE (%) OF ADULTS REACHING THE RECOMMENDED PHYSICAL ACTIVITY LEVELS, 2014 ADULTS (16 84 YEARS)*

Bridging Innovation and Business

Programme Workshop Drug Discovery DDD innova(on: Financing & Re- purposing

A Strategic Innovation Program in Medical Technology

Israeli Biotechnology Strategy Project. Realizing Our Potential

SUMMER COURSES 2012 Nordic Centre at Fudan University. Doing Business in China Introduction to Modern China

Groundbreaking Collaborative Clinical Trial Launched

BioForum 2012 Central European Forum of Biotechnology and Innovative BioEconomy 23rd-24th May 2012, Brno Date & Venue Date Venue

The Commercialization of Technology Concepts into Medical Products

Year-end report 2006 Prevas AB (publ), corporate reg. no

VIRGINIA SMALL BUSINESS FINANCING AUTHORITY

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

Strategic Innovation Agenda for Smart Sustainable Cities. Urban living lab, 25 May 2016 Olga Kordas

Gröna Tåget [grœ:na 'tɔ:gɛt] to make train travel more attractive

An Introduction to Packbridge

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

RETAIL MARKET IN SWEDEN

Active Biotech Group Interim Report 1 January 30 September 1999

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

Universities, Patents and Innovation: What s in it for the entrepreneur?

Investor Growth Capital Stephen Campe

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY

June Marcus Holgersson. Page 1 of 5

OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION

Transcription:

Biotech statistics used for: - International benchmarking - Strategy development - Policy decisions Anna Sandström The Swedish Governmental Agency for Innovation Systems VINNOVA

Efficient innovation systems From idea to product and/or services VINNOVA s mission is to promote sustainable growth by developing effective innovation systems and financing problem-oriented research Innovation systems analyses and international benchmarking for national strategy development Interaction between Business Research Public Sector VINNOVA: about 170 employees and a budget of almost 140 MEuro 2006

Idea Product Service Private foundations (e.g. for specific diseases) Swedish Foundation for Strategic Research (strategic research, peer review but top down choice of areas) Swedish Research Council (basic research, peer review) VINNOVA (needs driven research and improved innovation systems) Innovation Bridge (seed financing, incubators) Swedish Industrial Development Fund (semi public VC) Venture Capital Companies Universities and the healthcare sector Life Science Industry

Development of a National Biotech Strategy Examples of analyses used as input to the process Industry Production Bibliometry Pipeline Interviews Workshops Dialogue Committee Strategy Political process Foresight

Strategy for growth Biotechnology World International alliances Sweden Academy Industry More effective commercialisation of science Strengthened excellent science base Internationally competitive business terms Increased knowledge, dialogue, cooperation and readiness Politics and society

variables

Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Broad R&D Narrow R&D Productdevelopment Consultancy Production Wtthout wtth without with product Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food NATIONAL MARKET (eg Malmoe/Lund) Region No. employees (eg 1301-1700) INTERNATIONAL MARKET Category (eg production) Marketing & sales Region (eg Malmoe/Lund)

Umeå Uppsala/Stockholm Linköping Gothenburg Other Malmoe/L Umeå Uppsala - Stockholm Linköping Gotheneburg Other Malmoe/Lund NATIONAL MARKET INTERNATIONAL MARKET Cluster profile Sweden - Biotechnology, Pharmaceuticals and Medical Technology Broad R&D Narrow R&D Production Wtthout wtth without with product Marketing & sales Productdevelopment Consultancy Drug discovery & Development Drug delivery Diagnostics Biotech medical technology CRO CMO Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Functional food

Share of employees in different business segments 40 700 employees in total Agrobiotech 1,3% Bioproduction 2,4% Biotech tools & supplies 9% Environmental biotech 0,1% Functional food 0,2% Medical technology 26% Drug discovery & development 48% CMO 2,9% CRO 1,8% Biotech medical technology 4,5% Diagnostics 3,0% Drug delivery 0,5%

No. employees in different categories Broad R&D with product Broad R&D + product 11 050 Broad R&D Broad R&D/large pipeline yet without product 220 Narrow R&D with product Narrow R&D + product 750 Narrow R&D Narrow R&D yet without product 320 Own productdevelopment Product development Consultancy Konsult/CRO 870 3 980 Production units in companies with R&D and with more than 500 employees. Production Marketing and sales Production Sales Produktionsenheter inom 15 000 företag med mer än 500 anställda i Sverige och som även bedriver forskning och utveckling. 8 550 0 5000 10000 15000 20000 No. employees

Regional distribution of the Swedish Life Science industry Other parts of Sweden 3% Umeå 2% Gothenburg 19 % Stockholm/ Uppsala 58% Linköping 1% Malmoe/ Lund 17%

Development 1997-2003 216 companies with 22 400 employees 25 000 25000 20 000 15 000 10 000 20000 15000 10000 Biotech firms Pharmacia related companies 5000 5 000 Astra/AstraZeneca No. Employees 0 1997 1998 1999 2000 2001 2002 2003 1997 2003

Biotech + Astra/AstraZeneca & Pharmacia related companies 216 companies with 22 400 employees (2003) Astra/AstraZeneca Pharmacia related companies Other biotech companies 12000 No. employees 10 10000 8000 6000 5000 AstraZeneca Astra 4000 2000 0 1997 2003 No. employees 9000 8000 Biacore GE Healthcare Quintiles 7000 Amersham Bioscience 5000 6000 Active Biotech 5000 5000 Fresenius Kabi Pharmacia Biovitrum 4000 Octapharma Pharmacia 3000 Diagnostics Pfizer 2000 1000 0 1997 2003 1997 1998 1999 2000 2001 2002 2003 5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 No.employees 1997 2003 1997 1998 1999 2000 2001 2002 2003 + 5,5 percent/year, Total + 38 percent Growth of the number of employees 1997-2003 + 3,0 percent/year, Total + 19 percent + 6,2 percent/year, Total + 43 percent

Cluster Profile, SWEDEN Biotechnology, Pharmaceuticals Medical Technology (Excluding national market and marketing/sales) Broad R&D with product Broad R&D yet without prod Narrow R&D with product Narrow R&D yet without prod Own product development Consultancy Production Business segments: Drug discovery & development Drug delivery Diagnostics Biotech medical technology CRO Umeå Uppsala Stockholm Strängnäs Linköping Gothenburg Other Malmoe/Lund K10-BP1231 Medical technology Biotech tools & supplies Bioproduction Agrobiotech Environmental biotechnology Medicon Valley Copenhagen